Skip to main content
Top
Published in: Langenbeck's Archives of Surgery 8/2016

01-12-2016 | ORIGINAL ARTICLE

Identification of patients at risk for renal impairment after living donor kidney transplantation

Authors: Alexander Kaltenborn, Almut Nolte, Ysabell Schwager, Simon A. Littbarski, Nikos Emmanouilidis, Viktor Arelin, Jürgen Klempnauer, Harald Schrem

Published in: Langenbeck's Archives of Surgery | Issue 8/2016

Login to get access

Abstract

Purpose

Outcome after living donor kidney transplantation is highly relevant, since recipient and donor were exposed to notable harm. Reliable identification of risk factors is necessary.

Methods

Three hundred sixty-six living donor kidney transplants were included in this observational retrospective study. Relevant risk factors for renal impairment 1 year after transplantation and delayed graft function were identified with univariable and multivariable binary logistic regression and ordinal regression analysis.

Results

Eighty-four patients (26.6 %) suffered from renal impairment KDIGO stage ≥4 1 year post-transplant; median estimated glomerular filtration rate was 35.3 ml/min. In multivariable ordinal regression, male recipient sex (p < 0.001), recipient body mass index (p = 0.006), donor age (p = 0.002) and high percentages of panel reactive antibodies (p = 0.021) were revealed as independent risk factors for higher KDIGO stages. After adjustment for post-transplant data, recipient male sex (p < 0.001), donor age (p = 0.026) and decreased early renal function at the first post-transplant outpatient visit (p < 0.001) were identified as independent risk factors. Delayed graft function was independently associated with long stay on the waiting list (p = 0.011), high donor body mass index (p = 0.043), prolonged warm ischemic time (p = 0.016) and the presence of preformed donor-specific antibodies (p = 0.043).

Conclusions

Broadening the donor pool with non-blood related donors seems to be legitimate, although with respect to careful medical selection, since donor age in combination with male recipient sex were shown to be risk factors for decreased graft function. Warm ischemic time and waiting time need to be kept as short as possible to avoid delayed graft function. Transplantation across HLA and ABO borders did not affect outcome significantly.
Literature
1.
2.
go back to reference Gourishankar S, Grebe SO, Mueller TF (2013) Prediction of kidney graft failure using clinical scoring tools. Clin Transplant 27:517–522CrossRefPubMed Gourishankar S, Grebe SO, Mueller TF (2013) Prediction of kidney graft failure using clinical scoring tools. Clin Transplant 27:517–522CrossRefPubMed
3.
go back to reference Segev DL (2012) Innovative strategies in living donor kidney transplantation. Nat Rev Nephrol 8:332–338CrossRefPubMed Segev DL (2012) Innovative strategies in living donor kidney transplantation. Nat Rev Nephrol 8:332–338CrossRefPubMed
4.
go back to reference Cacho DT, Piqué AA, Cusi LI, Reyes LI, Salinas FO, del Pozo RG (2005) Living donor renal transplantation: prognostic factors on graft survival. Transplant Proc 37:3679–3681CrossRefPubMed Cacho DT, Piqué AA, Cusi LI, Reyes LI, Salinas FO, del Pozo RG (2005) Living donor renal transplantation: prognostic factors on graft survival. Transplant Proc 37:3679–3681CrossRefPubMed
5.
go back to reference Hariharan S, McBride MA, Cherikh WS, Tolleris CB, Bresnahan BA, Johnson CP (2002) Post-transplant renal function in the first year predicts long-term kidney transplant survival. Kidney Int 62:311–318CrossRefPubMed Hariharan S, McBride MA, Cherikh WS, Tolleris CB, Bresnahan BA, Johnson CP (2002) Post-transplant renal function in the first year predicts long-term kidney transplant survival. Kidney Int 62:311–318CrossRefPubMed
6.
go back to reference Reese PP, Boudville N, Garg AX (2015) Living kidney donation: outcomes, ethics, and uncertainty. Lancet 385:2003–2013CrossRefPubMed Reese PP, Boudville N, Garg AX (2015) Living kidney donation: outcomes, ethics, and uncertainty. Lancet 385:2003–2013CrossRefPubMed
8.
go back to reference Stevens PE, Levin A, Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members (2013) Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med 158:825–830CrossRefPubMed Stevens PE, Levin A, Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members (2013) Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med 158:825–830CrossRefPubMed
9.
go back to reference Levey AS, Coresh J, Greene T et al (2007) Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem 53:766–772CrossRefPubMed Levey AS, Coresh J, Greene T et al (2007) Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem 53:766–772CrossRefPubMed
10.
go back to reference Tanriover B, Fernandez S, Campenot ES, et al. (2015) Live donor renal anatomic asymmetry and posttransplant renal function. Transplantation Tanriover B, Fernandez S, Campenot ES, et al. (2015) Live donor renal anatomic asymmetry and posttransplant renal function. Transplantation
11.
go back to reference Terasaki PI, Cecka JM, Gjertson DW, Takemoto S (1995) High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med 333:333–336CrossRefPubMed Terasaki PI, Cecka JM, Gjertson DW, Takemoto S (1995) High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med 333:333–336CrossRefPubMed
12.
go back to reference Jinfeng L, Jia L, Tao G, Wenjun S, Xinlu P, Yonghua F, Guiwen F (2015) Donor kidney glomerular filtration rate and donor/recipient body surface area ratio influence graft function in living related kidney transplantation. Ren Fail 37:576–581CrossRefPubMed Jinfeng L, Jia L, Tao G, Wenjun S, Xinlu P, Yonghua F, Guiwen F (2015) Donor kidney glomerular filtration rate and donor/recipient body surface area ratio influence graft function in living related kidney transplantation. Ren Fail 37:576–581CrossRefPubMed
13.
go back to reference Hellegering J, Visser J, Kloke HJ, D’Ancona FC, Hoitsma AJ, van der Vliet JA, Warlé MC (2013) Poor early graft function impairs long-term outcome in living donor kidney transplantation. World J Urol 31:901–906CrossRefPubMed Hellegering J, Visser J, Kloke HJ, D’Ancona FC, Hoitsma AJ, van der Vliet JA, Warlé MC (2013) Poor early graft function impairs long-term outcome in living donor kidney transplantation. World J Urol 31:901–906CrossRefPubMed
14.
go back to reference Alvarez S, Boltansky A, Ursu M, Carvajal D, Innocenti G, Vukusich A, Carreaux L (2010) Prediction of renal function after living donor kidney transplantation. Transplant Proc 42:260–261CrossRefPubMed Alvarez S, Boltansky A, Ursu M, Carvajal D, Innocenti G, Vukusich A, Carreaux L (2010) Prediction of renal function after living donor kidney transplantation. Transplant Proc 42:260–261CrossRefPubMed
15.
go back to reference Lefaucheur C, Suberbielle-Boissel C, Hill GS et al (2008) Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation. Am J Transplant 8:324–331CrossRefPubMed Lefaucheur C, Suberbielle-Boissel C, Hill GS et al (2008) Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation. Am J Transplant 8:324–331CrossRefPubMed
16.
go back to reference Malheiro J, Tafulo S, Dias L, Martins LS, Fonseca I, Beirão I, Castro-Henriques A, Cabrita A (2015) Analysis of preformed donor-specific anti-HLA antibodies characteristics for prediction of antibody-mediated rejection in kidney transplantation. Transpl Immunol 32:66–71CrossRefPubMed Malheiro J, Tafulo S, Dias L, Martins LS, Fonseca I, Beirão I, Castro-Henriques A, Cabrita A (2015) Analysis of preformed donor-specific anti-HLA antibodies characteristics for prediction of antibody-mediated rejection in kidney transplantation. Transpl Immunol 32:66–71CrossRefPubMed
17.
go back to reference Salvadé I, Aubert V, Venetz JP, Golshayan D, Saouli AC, Matter M, Rotman S, Pantaleo G, Pascual M (2016) Clinically-relevant threshold of preformed donor-specific anti-HLA antibodies in kidney transplantation. Hum Immunol 77:483–489CrossRefPubMed Salvadé I, Aubert V, Venetz JP, Golshayan D, Saouli AC, Matter M, Rotman S, Pantaleo G, Pascual M (2016) Clinically-relevant threshold of preformed donor-specific anti-HLA antibodies in kidney transplantation. Hum Immunol 77:483–489CrossRefPubMed
18.
go back to reference Bachelet T, Martinez C, Del Bello A, Couzi L, Kejji S, Guidicelli G, Lepreux S, Visentin J, Congy-Jolivet N, Rostaing L, Taupin JL, Kamar N, Merville P (2016) Deleterious impact of donor-specific anti-HLA antibodies toward HLA-Cw and HLA-DP in kidney transplantation. Transplantation 100:159–166CrossRefPubMed Bachelet T, Martinez C, Del Bello A, Couzi L, Kejji S, Guidicelli G, Lepreux S, Visentin J, Congy-Jolivet N, Rostaing L, Taupin JL, Kamar N, Merville P (2016) Deleterious impact of donor-specific anti-HLA antibodies toward HLA-Cw and HLA-DP in kidney transplantation. Transplantation 100:159–166CrossRefPubMed
19.
go back to reference Sicard A, Amrouche L, Suberbielle C, Carmagnat M, Candon S, Thervet E, Delahousse M, Legendre C, Chatenoud L, Snanoudj R (2014) Outcome of kidney transplantations performed with preformed donor-specific antibodies of unknown etiology. Am J Transplant 14:193–201CrossRefPubMed Sicard A, Amrouche L, Suberbielle C, Carmagnat M, Candon S, Thervet E, Delahousse M, Legendre C, Chatenoud L, Snanoudj R (2014) Outcome of kidney transplantations performed with preformed donor-specific antibodies of unknown etiology. Am J Transplant 14:193–201CrossRefPubMed
20.
go back to reference Becker LE, Süsal C, Morath C (2013) Kidney transplantation across HLA and ABO antibody barriers. Curr Opin Organ Transplant 18:445–454PubMed Becker LE, Süsal C, Morath C (2013) Kidney transplantation across HLA and ABO antibody barriers. Curr Opin Organ Transplant 18:445–454PubMed
21.
go back to reference Habicht A, Bröcker V, Blume C et al (2011) Increase of infectious complications in ABO-incompatible kidney transplant recipients—a single centre experience. Nephrol Dial Transplant 26:4124–4131CrossRefPubMed Habicht A, Bröcker V, Blume C et al (2011) Increase of infectious complications in ABO-incompatible kidney transplant recipients—a single centre experience. Nephrol Dial Transplant 26:4124–4131CrossRefPubMed
22.
go back to reference Halazun KJ, Al-Mukhtar A, Aldouri A, Willis S, Ahmad N (2007) Warm ischemia in transplantation: search for a consensus definition. Transplant Proc 39:1329–1331CrossRefPubMed Halazun KJ, Al-Mukhtar A, Aldouri A, Willis S, Ahmad N (2007) Warm ischemia in transplantation: search for a consensus definition. Transplant Proc 39:1329–1331CrossRefPubMed
23.
go back to reference Tennankore KK, Kim SJ, Alwayn IP, Kiberd BA (2016) Prolonged warm ischemia time is associated with graft failure and mortality after kidney transplantation. Kidney Int 89:648–658CrossRefPubMed Tennankore KK, Kim SJ, Alwayn IP, Kiberd BA (2016) Prolonged warm ischemia time is associated with graft failure and mortality after kidney transplantation. Kidney Int 89:648–658CrossRefPubMed
24.
go back to reference Secin FP (2008) Importance and limits of ischemia in renal partial surgery: experimental and clinical research. Adv Urol 2008:102461CrossRefPubMedCentral Secin FP (2008) Importance and limits of ischemia in renal partial surgery: experimental and clinical research. Adv Urol 2008:102461CrossRefPubMedCentral
25.
go back to reference Rossi AP, Vella JP (2015) Hypertension, living kidney donors, and transplantation: where are we today? Adv Chronic Kidney Dis 22:154–164CrossRefPubMed Rossi AP, Vella JP (2015) Hypertension, living kidney donors, and transplantation: where are we today? Adv Chronic Kidney Dis 22:154–164CrossRefPubMed
26.
go back to reference Pelletier RP, Phillips GS, Rajab A, Pesavento TE, Henry ML (2014) Effects of cardiovascular comorbidity adjustment on SRTR risk-adjusted cox proportional hazard models of graft survival. Transplantation 97:686–693PubMed Pelletier RP, Phillips GS, Rajab A, Pesavento TE, Henry ML (2014) Effects of cardiovascular comorbidity adjustment on SRTR risk-adjusted cox proportional hazard models of graft survival. Transplantation 97:686–693PubMed
27.
go back to reference Zhou JY, Cheng J, Huang HF, Shen Y, Jiang Y, Chen JH (2013) The effect of donor-recipient gender mismatch on short- and long-term graft survival in kidney transplantation: a systematic review and meta-analysis. Clin Transplant 27:764–771PubMed Zhou JY, Cheng J, Huang HF, Shen Y, Jiang Y, Chen JH (2013) The effect of donor-recipient gender mismatch on short- and long-term graft survival in kidney transplantation: a systematic review and meta-analysis. Clin Transplant 27:764–771PubMed
28.
go back to reference Müller V, Szabó A, Viklicky O et al (1999) Sex hormones and gender-related differences: their influence on chronic renal allograft rejection. Kidney Int 55:2011–2020CrossRefPubMed Müller V, Szabó A, Viklicky O et al (1999) Sex hormones and gender-related differences: their influence on chronic renal allograft rejection. Kidney Int 55:2011–2020CrossRefPubMed
29.
go back to reference Antus B, Yao Y, Song E, Liu S, Lutz J, Heemann U (2002) Opposite effects of testosterone and estrogens on chronic allograft nephropathy. Transpl Int 15:494–501CrossRefPubMed Antus B, Yao Y, Song E, Liu S, Lutz J, Heemann U (2002) Opposite effects of testosterone and estrogens on chronic allograft nephropathy. Transpl Int 15:494–501CrossRefPubMed
30.
go back to reference Gratwohl A, Döhler B, Stern M, Opelz G (2008) H-Y as a minor histocompatibility antigen in kidney transplantation: a retrospective cohort study. Lancet 372:49–53CrossRefPubMed Gratwohl A, Döhler B, Stern M, Opelz G (2008) H-Y as a minor histocompatibility antigen in kidney transplantation: a retrospective cohort study. Lancet 372:49–53CrossRefPubMed
31.
go back to reference Keith DS, Patrie JT (2011) H-Y antigen incompatibility not associated with adverse immunologic graft outcomes: deceased donor pair analysis of the OPTN database. J Transplant 2011:148457CrossRefPubMedPubMedCentral Keith DS, Patrie JT (2011) H-Y antigen incompatibility not associated with adverse immunologic graft outcomes: deceased donor pair analysis of the OPTN database. J Transplant 2011:148457CrossRefPubMedPubMedCentral
32.
go back to reference Fuggle SV, Allen JE, Johnson RJ, Collett D, Mason PD, Dudley C et al (2010) Factors affecting graft and patient survival after live donor kidney transplantation in the UK. Transplantation 89:694–701CrossRefPubMed Fuggle SV, Allen JE, Johnson RJ, Collett D, Mason PD, Dudley C et al (2010) Factors affecting graft and patient survival after live donor kidney transplantation in the UK. Transplantation 89:694–701CrossRefPubMed
33.
go back to reference Øien CM, Reisaeter AV, Leivestad T, Dekker FW, Line PD, Os I (2007) Living donor kidney transplantation: the effects of donor age and gender on short- and long-term outcomes. Transplantation 83:600–606CrossRefPubMed Øien CM, Reisaeter AV, Leivestad T, Dekker FW, Line PD, Os I (2007) Living donor kidney transplantation: the effects of donor age and gender on short- and long-term outcomes. Transplantation 83:600–606CrossRefPubMed
Metadata
Title
Identification of patients at risk for renal impairment after living donor kidney transplantation
Authors
Alexander Kaltenborn
Almut Nolte
Ysabell Schwager
Simon A. Littbarski
Nikos Emmanouilidis
Viktor Arelin
Jürgen Klempnauer
Harald Schrem
Publication date
01-12-2016
Publisher
Springer Berlin Heidelberg
Published in
Langenbeck's Archives of Surgery / Issue 8/2016
Print ISSN: 1435-2443
Electronic ISSN: 1435-2451
DOI
https://doi.org/10.1007/s00423-016-1492-2

Other articles of this Issue 8/2016

Langenbeck's Archives of Surgery 8/2016 Go to the issue